Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Prion Hypothesis of Parkinson’s Disease
Yaping Chu, Jeffrey H. Kordower
Current Neurology and Neuroscience Reports (2015) Vol. 15, Iss. 5
Closed Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease
Nolwen L. Rey, Jennifer A. Steiner, Nazia Maroof, et al.
The Journal of Experimental Medicine (2016) Vol. 213, Iss. 9, pp. 1759-1778
Open Access | Times Cited: 343
Pluripotent stem cell-based therapy for Parkinson’s disease: Current status and future prospects
Kai‐Christian Sonntag, Bin Song, Nayeon Lee, et al.
Progress in Neurobiology (2018) Vol. 168, pp. 1-20
Open Access | Times Cited: 116
miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease
Márcia Cristina Teixeira dos Santos, Miguel Arturo Barreto-Sanz, Bruna Renata S. Correia, et al.
Oncotarget (2018) Vol. 9, Iss. 25, pp. 17455-17465
Open Access | Times Cited: 115
ɑ-Synuclein strains and seeding in Parkinson’s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences
Wouter Peelaerts, Luc Bousset, Veerle Baekelandt, et al.
Cell and Tissue Research (2018) Vol. 373, Iss. 1, pp. 195-212
Open Access | Times Cited: 110
Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes
Yaping Chu, Scott Muller, Adriana Tavares, et al.
Brain (2019) Vol. 142, Iss. 11, pp. 3565-3579
Open Access | Times Cited: 95
Understanding the pathogenesis of multiple system atrophy: state of the art and future perspectives
Giacomo Monzio Compagnoni, Alessio Di Fonzo
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 79
Delivering the Promise of Gene Therapy with Nanomedicines in Treating Central Nervous System Diseases
Meihua Luo, Leo Kit Cheung Lee, Bo Peng, et al.
Advanced Science (2022) Vol. 9, Iss. 26
Open Access | Times Cited: 43
Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
Sonia George, Patrik Brundin
Journal of Parkinson s Disease (2015) Vol. 5, Iss. 3, pp. 413-424
Open Access | Times Cited: 79
Oleuropein aglycone stabilizes the monomeric α-synuclein and favours the growth of non-toxic aggregates
Luana Palazzi, Elena Bruzzone, Giovanni Bisello, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 65
Potential Role of Natural Polyphenols against Protein Aggregation Toxicity: In Vitro, In Vivo, and Clinical Studies
Gabriela Henrı́quez, Alejandra Gomez‐Cadena, Erick Guerrero, et al.
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 19, pp. 2915-2934
Closed Access | Times Cited: 64
Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson’s disease
Gunasingh Masilamoni, Yoland Smith
Journal of Neural Transmission (2017) Vol. 125, Iss. 3, pp. 337-363
Open Access | Times Cited: 63
Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications
Denis Ottolini, Tito Calì, Ildikò Szabó, et al.
Biological Chemistry (2016) Vol. 398, Iss. 1, pp. 77-100
Closed Access | Times Cited: 61
Immunotherapy in Parkinson’s disease: Current status and future directions
Diptaman Chatterjee, Jeffrey H. Kordower
Neurobiology of Disease (2019) Vol. 132, pp. 104587-104587
Open Access | Times Cited: 55
Neurons and Glia Interplay in α-Synucleinopathies
Panagiota Mavroeidi, Maria Xilouri
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4994-4994
Open Access | Times Cited: 43
A comprehensive analysis of SNCA‐related genetic risk in sporadic parkinson disease
Lasse Pihlstrøm, Cornelis Blauwendraat, Chiara Cappelletti, et al.
Annals of Neurology (2018) Vol. 84, Iss. 1, pp. 117-129
Open Access | Times Cited: 58
Bent out of shape: α‐Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's disease
Esteban Luna, Kelvin C. Luk
FEBS Letters (2015) Vol. 589, Iss. 24PartA, pp. 3749-3759
Open Access | Times Cited: 57
Differential Aggregation and Phosphorylation of Alpha Synuclein in Membrane Compartments Associated With Parkinson Disease
Ana Canerina‐Amaro, Daniel Pereda, Mario Dı́az, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 46
Mixed pathology as a rule, not exception: Time to reconsider disease nosology
Yaping Chu, Warren D. Hirst, Jeffrey H. Kordower
Handbook of clinical neurology (2023), pp. 57-71
Closed Access | Times Cited: 13
Small molecule modulators of Alpha-Synuclein Aggregation and Toxicity: Pioneering an Emerging Arsenal Against Parkinson’s Disease
Ishfaq Ahmad Ahanger, Tanveer Ali Dar
Ageing Research Reviews (2024) Vol. 101, pp. 102538-102538
Closed Access | Times Cited: 5
Nonhuman Primate Models of Neurodegenerative Disorders
Marina E. Emborg
ILAR Journal (2017) Vol. 58, Iss. 2, pp. 190-201
Open Access | Times Cited: 48
Critical appraisal of pathology transmission in the α-synuclein fibril model of Lewy body disorders
Negin Nouraei, Daniel M. Mason, Kristin M. Miner, et al.
Experimental Neurology (2017) Vol. 299, pp. 172-196
Open Access | Times Cited: 40
Parkinson’s disease in the older patient
Simon J.G. Lewis, Sanjay Gangadharan, Chandrasekhara Padmakumar
Clinical Medicine (2016) Vol. 16, Iss. 4, pp. 376-378
Open Access | Times Cited: 38
Parkinsonian features in aging GFAP.HMOX1 transgenic mice overexpressing human HO-1 in the astroglial compartment
Wei Song, Marisa Cressatti, Hillel Zukor, et al.
Neurobiology of Aging (2017) Vol. 58, pp. 163-179
Closed Access | Times Cited: 35
Potential for Therapeutic-Loaded Exosomes to Ameliorate the Pathogenic Effects of α-Synuclein in Parkinson’s Disease
David J. Rademacher
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1187-1187
Open Access | Times Cited: 10
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12613-12613
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top